VEGF-2: Phase I/II studies update

Vascular Genetics Inc., Research Triangle Park, N.C. Product: VEGF-2 Business: Cardiovascular Therapeutic category: Angiogenesis, Gene therapy Target: VEGF-2 receptors Description: Vascular endothelia...